Product Information
BENAZEPRIL HCL 40 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1011 per EA under NDC 23155075201. Its NADAC has been published 190 times since Feb 15, 2023.
FDA first approved this application on Feb 11, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155075201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076267FDA Approved
2/11/2004
TE Code
AB
On Market Since
8/20/2022
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL HCL 40 MG TABLET has been published 190 times since Feb 15, 2023, and over the history we have for it it has risen 5.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1011 per EA |
|---|---|
| All-time high | $0.1036 (Jul 12, 2023) |
| All-time low | $0.0613 (Nov 20, 2024) |
| 52-week high | $0.1011 |
| 52-week low | $0.0955 |
| Median price | $0.0933 |
| Average price | $0.0902 |
| Largest weekly change | +31.9% (Aug 21, 2024) |
| Weeks tracked | 190 |
| Tracking since | Feb 15, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Benazepril Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENAZEPRIL HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL HCL 40 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.1011 per EA (NDC 23155075201), effective Sep 30, 2026.
How has the price of BENAZEPRIL HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL HCL 40 MG TABLET has risen 5.4%. It has been tracked across 190 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL HCL 40 MG TABLET?
Since Feb 15, 2023, the NADAC for BENAZEPRIL HCL 40 MG TABLET has ranged from a low of $0.0613 (Nov 20, 2024) to a high of $0.1036 (Jul 12, 2023), with a median of $0.0933 per EA.
Are there cheaper alternatives to BENAZEPRIL HCL 40 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL HCL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BENAZEPRIL HCL 40 MG TABLET?
BENAZEPRIL HCL 40 MG TABLET (NDC 23155075201) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.